By Associate Professor Amany Zekry

Journal articles

Sievert W; Razavi H; Thompson A; Zekry A; Dore GJ; Roberts SK, 2015, 'HCV‐infected patients need access now to new direct‐acting antiviral agents to avert liver‐related deaths', The Medical Journal of Australia, 202, pp. 479 - 479, http://dx.doi.org/10.5694/mja15.00165

Muir AJ; Arora S; Everson G; Flisiak R; George J; Ghalib R; Gordon SC; Gray T; Greenbloom S; Hassanein T; Hillson J; Horga MA; Jacobson IM; Jeffers L; Kowdley KV; Lawitz E; Lueth S; Rodriguez-Torres M; Rustgi V; Shemanski L; Shiffman ML; Srinivasan S; Vargas HE; Vierling JM; Xu D; Lopez-Talavera JC; Zeuzem S, 2014, 'A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection', Journal of Hepatology, 61, pp. 1238 - 1246, http://dx.doi.org/10.1016/j.jhep.2014.07.022

Raghuraman S; Lloyd AR; Zekry A, 2014, 'Obese visceral adipose tissue exhibits altered T cell trafficking patterns and confers a unique phenotype to tissue-resident T cells', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 29, pp. 23 - 23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bruggmann P; Berg T; Øvrehus ALH; Moreno C; Brandão Mello CE; Roudot-Thoraval F; Marinho RT; Sherman M; Ryder SD; Sperl J; Akarca U; Balık I; Bihl F; Bilodeau M; Blasco AJ; Buti M; Calinas F; Calleja JL; Cheinquer H; Christensen PB; Clausen M; Coelho HSM; Cornberg M; Cramp ME; Dore GJ; Doss W; Duberg AS; El-Sayed MH; Ergör G; Esmat G; Estes C; Falconer K; Félix J; Ferraz MLG; Ferreira PR; Frankova S; García-Samaniego J; Gerstoft J; Giria JA; Gonçales FL; Gower E; Gschwantler M; Guimarães Pessôa M; Hézode C; Hofer H; Husa P; Idilman R; Kåberg M; Kaita KDE; Kautz A; Kaymakoglu S; Krajden M; Krarup H; Laleman W; Lavanchy D; Lázaro P; Marotta P; Mauss S; Mendes Correa MC; Müllhaupt B; Myers RP; Negro F; Nemecek V; Örmeci N; Parkes J; Peltekian KM; Ramji A; Razavi H; Reis N; Roberts SK; Rosenberg WM; Sarmento-Castro R; Sarrazin C; Semela D; Shiha GE; Sievert W; Stärkel P; Stauber RE; Thompson AJ; Urbanek P; van Thiel I; Van Vlierberghe H; Vandijck D; Vogel W; Waked I; Wedemeyer H; Weis N; Wiegand J; Yosry A; Zekry A; Van Damme P; Aleman S; Hindman SJ, 2014, 'Historical epidemiology of hepatitis C virus (HCV) in selected countries', Journal of viral hepatitis, 21, pp. 5 - 33, http://dx.doi.org/10.1111/jvh.12247

Wedemeyer H; Duberg AS; Buti M; Rosenberg WM; Frankova S; Esmat G; Örmeci N; Van Vlierberghe H; Gschwantler M; Akarca U; Aleman S; Balık I; Berg T; Bihl F; Bilodeau M; Blasco AJ; Brandão Mello CE; Bruggmann P; Calinas F; Calleja JL; Cheinquer H; Christensen PB; Clausen M; Coelho HSM; Cornberg M; Cramp ME; Dore GJ; Doss W; El-Sayed MH; Ergör G; Estes C; Falconer K; Félix J; Ferraz MLG; Ferreira PR; García-Samaniego J; Gerstoft J; Giria JA; Gonçales FL; Guimarães Pessôa M; Hézode C; Hindman SJ; Hofer H; Husa P; Idilman R; Kåberg M; Kaita KDE; Kautz A; Kaymakoglu S; Krajden M; Krarup H; Laleman W; Lavanchy D; Lázaro P; Marinho RT; Marotta P; Mauss S; Mendes Correa MC; Moreno C; Müllhaupt B; Myers RP; Nemecek V; Øvrehus ALH; Parkes J; Peltekian KM; Ramji A; Razavi H; Reis N; Roberts SK; Roudot-Thoraval F; Ryder SD; Sarmento-Castro R; Sarrazin C; Semela D; Sherman M; Shiha GE; Sperl J; Stärkel P; Stauber RE; Thompson AJ; Urbanek P; Van Damme P; van Thiel I; Vandijck D; Vogel W; Waked I; Weis N; Wiegand J; Yosry A; Zekry A; Negro F; Sievert W; Gower E, 2014, 'Strategies to manage hepatitis C virus (HCV) disease burden', Journal of viral hepatitis, 21, pp. 60 - 89, http://dx.doi.org/10.1111/jvh.12249

Razavi H; Waked I; Sarrazin C; Myers RP; Idilman R; Calinas F; Vogel W; Mendes Correa MC; Hézode C; Lázaro P; Akarca U; Aleman S; Balık I; Berg T; Bihl F; Bilodeau M; Blasco AJ; Brandão Mello CE; Bruggmann P; Buti M; Calleja JL; Cheinquer H; Christensen PB; Clausen M; Coelho HSM; Cramp ME; Dore GJ; Doss W; Duberg AS; El-Sayed MH; Ergör G; Esmat G; Falconer K; Félix J; Ferraz MLG; Ferreira PR; Frankova S; García-Samaniego J; Gerstoft J; Giria JA; Gonçales FL; Gower E; Gschwantler M; Guimarães Pessôa M; Hindman SJ; Hofer H; Husa P; Kåberg M; Kaita KDE; Kautz A; Kaymakoglu S; Krajden M; Krarup H; Laleman W; Lavanchy D; Marinho RT; Marotta P; Mauss S; Moreno C; Murphy K; Negro F; Nemecek V; Örmeci N; Øvrehus ALH; Parkes J; Pasini K; Peltekian KM; Ramji A; Reis N; Roberts SK; Rosenberg WM; Roudot-Thoraval F; Ryder SD; Sarmento-Castro R; Semela D; Sherman M; Shiha GE; Sievert W; Sperl J; Stärkel P; Stauber RE; Thompson AJ; Urbanek P; Van Damme P; van Thiel I; Van Vlierberghe H; Vandijck D; Wedemeyer H; Weis N; Wiegand J; Yosry A; Zekry A; Cornberg M; Müllhaupt B; Estes C, 2014, 'The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm', Journal of viral hepatitis, 21, pp. 34 - 59, http://dx.doi.org/10.1111/jvh.12248

Martinez D; Palmer C; Simar D; Cameron B; Nguyen N; Aggarwal V; Lloyd A; Zekry A, 2014, 'Characterization of the cytokine milieu associated with the upregulation of IL-6 and suppressor of cytokine 3 in chronic hepatitis C treatment non-responders', Liver International, http://dx.doi.org/10.1111/liv.12473

Roberts SK; Mitchell J; Leung R; Booth D; Bollipo S; Ostapowicz G; Sloss A; Mccaughan GW; Dore GJ; Thompson A; Crawford DH; Sievert W; Weltman M; Cheng W; George J; Angus P; Chu G; Cornwall M; Douglas M; Hallinan R; Haque M; Hawkin G; Jackson H; Johnson R; Kronborg I; Lee A; Leggett B; Mire ML; Levy M; Lubel J; MacQuillan G; Masson J; McDonald J; McGarity B; Mollison L; Nicoll A; Ombiga J; Riordan S; Strasser S; Thompson A; Watson J; Wenman J; Wigg A; Zekry A, 2014, 'Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studies', Journal of Gastroenterology and Hepatology (Australia), 29, pp. 179 - 184, http://dx.doi.org/10.1111/jgh.12424

Sievert W; Razavi H; Estes C; Thompson AJ; Zekry A; Roberts SK; Dore GJ, 2014, 'Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia', Journal of Gastroenterology and Hepatology (Australia), 29, pp. 1 - 9, http://dx.doi.org/10.1111/jgh.12677

Nguyen N; de Esch C; Cameron B; Kumar RK; Zekry A; Lloyd AR, 2014, 'Positioning of leukocyte subsets in the portal and lobular compartments of hepatitis C virus-infected liver correlates with local chemokine expression', Journal of Gastroenterology and Hepatology (Australia), 29, pp. 860 - 869, http://dx.doi.org/10.1111/jgh.12462

Nguyen N; Hampartzoumian T; Cameron B; Palmer C; O'Toole S; Post J; Zekry A; Lloyd A, 2014, 'Regulation of T cell recruitment and inflammation in the human immunodeficiency virus/hepatitis C virus coinfected liver', Journal of Gastroenterology and Hepatology (Australia), 29, pp. 1535 - 1543, http://dx.doi.org/10.1111/jgh.12543

Nguyen N; Luciani F; Cameron B; Keoshkerian E; Zekry A; Lloyd A, 2012, '801 T CELLS CO-EXPRESSING CCR2, CCR5, CXCR3, AND CXCR6 ARE PREFERENTIALLY ENRICHED IN THE HCV-INFECTED LIVER', Journal of Hepatology, 56, pp. S313 - S313, http://dx.doi.org/10.1016/s0168-8278(12)60813-7

Guirgis M; Nusair F; Bu YM; Yan KK; Zekry A, 2012, 'Barriers Faced by Migrants in Accessing Healthcare for Viral Hepatitis Infection.', Internal Medicine Journal, 42, pp. 491 - 496, http://dx.doi.org/10.1111/j.1445-5994.2011.02647.x

Guirgis M; Yan KK; Bu YM; Zekry A, 2012, 'General practitioners' knowledge and management of viral hepatitis in the migrant population.', Internal Medicine Journal, 42, pp. 497 - 504, http://dx.doi.org/10.1111/j.1445-5994.2011.02440.x

Yan K; Zekry A, 2011, 'Standard Therapy for Genotypes 2/3', , pp. 90 - 96, http://dx.doi.org/10.1002/9781444346343.ch12

Patel K; Jhaveri R; George J; Qiang G; Kenedi C; Brown K; Cates C; Zekry A; Tillmann HL; Elliott L; Kilaru R; Albrecht J; Conrad A; McHutchison J, 2011, 'Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C', Journal of Viral Hepatitis, 18, pp. 331 - 337, http://dx.doi.org/10.1111/j.1365-2893.2010.01310.x

Zeuzem S; Sulkowski MS; Lawitz EJ; Rustgi VK; Rodriguez-Torres M; Bacon BR; Grigorescu M; Tice AD; Lurie Y; Cianciara J; Muir AJ; Cronin PW; Pulkstenis E; Subramanian GM; Mchutchison JG, 2010, 'Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-alpha in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 1', GASTROENTEROLOGY, 139, pp. 1257 - 1266, http://dx.doi.org/10.1053/j.gastro.2010.06.066

Nelson DR; Benhamou Y; Chuang W-L; Lawitz EJ; Rodriguez-Torres M; Flisiak R; Rasenack JWF; Kryczka W; Lee C-M; Bain VG; Pianko S; Patel K; Cronin PW; Pulkstenis E; Subramanian GM; Mchutchison JG, 2010, 'Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-alpha in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 2 or 3', GASTROENTEROLOGY, 139, pp. 1267 - +, http://dx.doi.org/10.1053/j.gastro.2010.06.062

Palmer CS; Dehart M; Zhang X; Feilotter H; Lloyd A; Zekry A, 2010, 'miR-135a*plays a key role in regulating lipogenesis and inflammation in liver diseases', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 25, pp. A128 - A128, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283321200338&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Nguyen N; De Esch C; Hampartzoumian T; Zekry A; Lloyd A, 2009, 'Fine positioning of T cell sub-populations in the chronic HCV-infected liver', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, pp. A284 - A284, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200175&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Palmer C; Zhang X; Feilotter H; Lloyd A; Zekry A, 2009, 'Hepatic micrornas expression in obese subjects with chronic HCV', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, pp. A285 - A285, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200178&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Nguyen N; Palmer C; Hampartzoumian T; Post J; Zekry A; Lloyd A, 2009, 'Intrahepatic chemokine expression and CD8+T cells in HIV/HCV co-infection compared to HCV mono-infection', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, pp. A289 - A289, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200187&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Guirgis M; Zekry A; Yan K; Bu YM; Lee A, 2009, 'Chronic hepatitis B infection in an Australian antenatal population: Seroprevalence and opportunities for better outcomes', Journal of Gastroenterology and Hepatology (Australia), 24, pp. 998 - 1001, http://dx.doi.org/10.1111/j.1440-1746.2009.05841.x

Zekry A, 2009, 'Cytokines and liver injury in chronic HCV genotype 4 infection', Journal of Gastroenterology and Hepatology, 24, pp. 332 - 335

Ward CL; Dev A; Rigby S; Symonds WT; Patel K; Zekry A; Pawlotsky JM; McHutchison JG, 2008, 'Interferon and ribavirin therapy does not select for resistance mutations in hepatitis C virus polymerase', Journal of Viral Hepatitis, 15, pp. 571 - 577, http://dx.doi.org/10.1111/j.1365-2893.2008.00980.x

Zekry A; Freiman J, 2008, 'Eltrombopag: Is this "24 karat gold platelet" treatment for thrombocytopenia in cirrhosis associated with hepatitis C?', Hepatology, 47, pp. 1418 - 1421, http://dx.doi.org/10.1002/hep.22300

Palmer C; Hampartzoumian T; Lloyd AR; Zekry A, 2008, 'A novel role for adiponectin in regulating the immune responses in chronic hepatitis C virus infection', Hepatology, 48, pp. 374 - 384, http://dx.doi.org/10.1002/hep.22387

Dev A; Kauf T; Zekry A; Patel K; Heller K; Schulman K; McHutchison J, 2008, 'Factors influencing the participation of gastroenterologists and hepatologists in clinical research', BMC Health Services Research, 8, pp. 1 - 11

Yan KK; Dinihan I; Freiman J; Zekry A, 2008, 'Sarcoidosis presenting with granulomatous uveitis induced by pegylated interferon and ribavirin therapy for hepatitis C', Internal Medicine Journal, 38, pp. 207 - 210, http://dx.doi.org/10.1111/j.1445-5994.2007.01625.x

Yan KK; Guirgis M; Dinh T; George J; Dev A; Lee A; Zekry A, 2008, 'Treatment responses in Asians and Caucasians with chronic hepatitis C infection', World Journal of Gastroenterology, 14, pp. 3416 - 3420

White IR; Patel K; Symonds WT; Dev A; Griffin P; Tsokanas N; Skehel M; Liu C; Zekry A; Cutler P; Gattu M; Rockey DC; Berrey MM; McHutchison JG, 2007, 'Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection', Journal of Translational Medicine, 5, http://dx.doi.org/10.1186/1479-5876-5-33

Zekry A; Yan K, 2007, 'Is re-treatment with peginterferon alpha-2a and ribavirin effective in patients with relapsed chronic hepatitis C?', NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 4, pp. 12 - 13, http://dx.doi.org/10.1038/ncpgasthep0694

Palmer C; Lloyd AR; Zekry A, 2007, 'Effect of adiponectin on the cellular immune response in chronic HCV infection', Hepatology, 46, pp. 440A - 440A, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000249910400459&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Zekry A; Yan KK, 2007, 'Is re-treatment with peginterferon alpha-2a and ribavirin effective in patients with relapsed chronic hepatitis C?', NATURE CLINICAL PRACTICE GASTROENTEROLOGY and HEPATOLOGY, 4, pp. 12 - 13

Palmer C; Lloyd AR; Yan KK; Hampartzoumian T; Zekry A, 2006, 'Effect of adipokines on T-CELL mediated anti-HCV immune responses', Hepatology, 44, pp. 297A - 298A, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000241362300290&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Scott D; Freiman J; Zekry A; Vonthethoff LW; Vollmer-Conner U; Hui JM, 2006, 'A novel noninvasive index for prediction of hepatic fibrosis in chronic hepatitis B virus infection', Journal of Gastroenterology and Hepatology, 21, pp. A300 - A300, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000247320600105&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Yan KK; George J; Freiman J; Craig P; Hui JM; Zekry A, 2006, 'Enhanced virological responses in genotype 4 hepatitis C virus infection: a case control study', Journal of Gastroenterology and Hepatology, 21, pp. A308 - A308

Yan KK; Dinihan I; Freiman J; Lawrence R; Zekry A, 2006, 'Sarcoidosis presenting with granulomatous uveitis induced by pegylated interferon and ribavirin therapy for hepatitis C', Journal of Gastroenterology and Hepatology, 21, pp. A323 - A323

Yan KK; Zekry A; Hui JM; Freiman J; George J, 2006, 'Virological responses in Asians receiving combination antiviral therapy for chronic hepatitis C virus infection', Journal of Gastroenterology and Hepatology, 21, pp. A334 - A334

Patel K; Zekry A; McHutchison JG, 2005, 'Steatosis and chronic hepatitis C virus infection: Mechanisms and significance', Clinics in Liver Disease, 9, pp. 399 - 410, http://dx.doi.org/10.1016/j.cld.2005.05.007

Zekry A; McHutchison JG; Diehl AM, 2005, 'Insulin resistance and steatosis in hepatitis C virus infection', Gut, 54, pp. 903 - 906, http://dx.doi.org/10.1136/gut.2004.059873

Zekry A; Patel K; McHutchison JG, 2005, 'Treatment of acute hepatitis C infection: More pieces of the puzzle?', Journal of Hepatology, 42, pp. 293 - 296, http://dx.doi.org/10.1016/j.jhep.2004.12.012

McHutchison J; Zekry A, 2004, 'Is the current standard therapy for hepatitis C of peginterferon and ribavirin an option for patients coinfected with HIV?', Nature Clinical Practice Gastroenterology and Hepatology, 1, pp. 70 - 71, http://dx.doi.org/10.1038/ncpgasthep0050

Zekry A; Patel K; Muir A; McHutchison JG, 2004, 'Tinkering and tailoring with HCV therapy: Can we get away with less?', Hepatology, 40, pp. 1249 - 1251, http://dx.doi.org/10.1002/hep.20513

Zekry A; Gleeson M; Guney S; McCaughan GW, 2004, 'A prospective cross-over study comparing the effect of mycophenolate versus azathioprine on allograft function and viral load in liver transplant recipients with recurrent chronic HCV infection', Liver Transplantation, 10, pp. 52 - 57, http://dx.doi.org/10.1002/lt.20000

McCaughan GW; Zekry A, 2004, 'Mechanisms of HCV reinfection and allograft damage after liver transplantation', Journal of Hepatology, 40, pp. 368 - 374, http://dx.doi.org/10.1016/j.jhep.2004.01.014

Zekry A; Whiting P; Crawford DH; Angus PW; Jeffrey GP; Padbury RT; Gane EJ; McCaughan GW; Koorey D; Strasser S; Verran D; Stewart G; Lynch S; Fawcett J; Strong R; Gow P; Berry R; Jones R; Dolan P; Kow L; Harley H; House A; Mictchell A; Jeffrey G; Munn S; McCall J, 2003, 'Liver transplantation for HCV-associated liver cirrhosis: Predictors of outcomes in a population with significant genotype 3 and 4 distribution', Liver Transplantation, 9, pp. 339 - 347, http://dx.doi.org/10.1053/jlts.2003.50063

McCaughan GW; Zekry A, 2003, 'Impact of immunosuppression on immunopathogenesis of liver damage in hepatitis C virus-infected recipients following liver transplantation', Liver Transplantation, 9, http://dx.doi.org/10.1053/jlts.2003.50269

ZEKRY A; WILLIAM R; MCCAUGHAN G, 2003, '33 Microarray analysis of intrahepatic gene expression in different patterns of HCV recurrence post liver transplant', Hepatology, 38, pp. 171 - 171, http://dx.doi.org/10.1016/s0270-9139(03)80076-9

McCaughan GW; Zekry A, 2002, 'Pathogenesis of hepatitis C virus recurrence in the liver allograft', Liver Transplantation, 8, pp. s7 - s13, http://dx.doi.org/10.1053/jlts.2002.35856

Back to profile page